Deogaonkar Kedar, Mehbod Amir A, Dawson John M, Transfeldt Ensor E
Twin Cities Spine Center, Minneapolis, MN.
Clin Spine Surg. 2018 Oct;31(8):E413-E417. doi: 10.1097/BSD.0000000000000686.
This is a retrospective cohort study.
This study aimed to determine whether the Fusion Risk Score (FRS) is valid for perioperative complications.
The FRS was previously formulated from a retrospective review of 364 fusion surgeries in patients over age 65. Patient demographics, comorbidities, surgical approach, levels, and osteotomies are incorporated in a weighted manner. This score correlated well with the risk of perioperative complications, operative time, estimated blood loss during surgery, and length of hospital stay.
A new cohort of patients was studied. Subjects were 65 years old or older and had undergone routine elective thoracic or lumbar fusion surgery. The FRS was calculated for each subject to estimate risk (low, medium, or high) for perioperative complications. Actual incidences of major complications in the first 90 days after the surgery were noted and statistically compared with the predicted risk. The FRS was compared with intensive care unit admittance, estimated blood loss, operative time, and hospital length of stay to determine whether the score was predictive.
In total, 51% of our patients were at low risk (FRS, 1-3) for perioperative complications; 43% were at medium risk (FRS, 4-9); and 7% were at high risk (FRS, over 9). A total of 8% in the low-risk group, 23% in the medium-risk group, and 67% in the high-risk group actually developed significant perioperative complications. Medium-risk and high-risk patients experienced proportionally more perioperative complications than did low-risk patients; the difference was highly statistically significant.
This study validated the association between the FRS and complications in the first 90 days after thoracolumbar spinal fusion surgery on the basis of patient and surgery characteristics. It also predicts the risk of intensive care unit admission, operative time, blood loss, and hospital length of stay.
这是一项回顾性队列研究。
本研究旨在确定融合风险评分(FRS)对围手术期并发症是否有效。
FRS先前是通过对364例65岁以上患者的融合手术进行回顾性分析得出的。患者人口统计学特征、合并症、手术方式、手术节段和截骨术均以加权方式纳入评分。该评分与围手术期并发症风险、手术时间、术中估计失血量及住院时间密切相关。
对一组新的患者进行研究。受试者年龄在65岁及以上,接受了常规择期胸腰椎融合手术。计算每位受试者的FRS以评估围手术期并发症风险(低、中或高)。记录术后前90天内主要并发症的实际发生率,并与预测风险进行统计学比较。将FRS与重症监护病房入住情况、估计失血量、手术时间和住院时间进行比较,以确定该评分是否具有预测性。
总体而言,51%的患者围手术期并发症风险低(FRS为1 - 3);43%为中度风险(FRS为4 - 9);7%为高风险(FRS超过9)。低风险组中实际发生严重围手术期并发症的患者占8%,中度风险组为23%,高风险组为67%。中度风险和高风险患者围手术期并发症的发生率高于低风险患者,差异具有高度统计学意义。
本研究基于患者和手术特征,验证了胸腰椎脊柱融合手术后FRS与术后90天内并发症之间的关联。它还能预测重症监护病房入住风险、手术时间、失血量和住院时间。